445 related articles for article (PubMed ID: 7622580)
41. Autocrine and paracrine regulation of tissue inhibitor of metalloproteinases, transin, and urokinase gene expression in metastatic and nonmetastatic mammary carcinoma cells.
Korczak B; Kerbel RS; Dennis JW
Cell Growth Differ; 1991 Jul; 2(7):335-41. PubMed ID: 1782152
[TBL] [Abstract][Full Text] [Related]
42. Chemotactic effect of urokinase plasminogen activator: a major role for mechanisms independent of its proteolytic or growth factor domains.
Poliakov AA; Mukhina SA; Traktouev DO; Bibilashvily RS; Gursky YG; Minashkin MM; Stepanova VV; Tkachuk VA
J Recept Signal Transduct Res; 1999 Nov; 19(6):939-51. PubMed ID: 10533982
[TBL] [Abstract][Full Text] [Related]
43. Invasion of connective tissue by human carcinoma cell lines: requirement for urokinase, urokinase receptor, and interstitial collagenase.
Ossowski L
Cancer Res; 1992 Dec; 52(24):6754-60. PubMed ID: 1333882
[TBL] [Abstract][Full Text] [Related]
44. Modulation of urokinase-type plasminogen activator by transforming growth factor beta1 in acetaldehyde-activated hepatic stellate cells.
Pérez-Liz G; Flores-Hernández J; Arias-Montaño JA; Reyes-Esparza JA; Rodríguez-Fragoso L
Pharmacology; 2005 Jan; 73(1):23-30. PubMed ID: 15452360
[TBL] [Abstract][Full Text] [Related]
45. Heparin stimulation of plasminogen activator secretion by macrophage-like cell line RAW264.7: role of the scavenger receptor.
Falcone DJ
J Cell Physiol; 1989 Aug; 140(2):219-26. PubMed ID: 2501315
[TBL] [Abstract][Full Text] [Related]
46. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy.
Lundgren CH; Sawa H; Sobel BE; Fujii S
Circulation; 1994 Oct; 90(4):1927-34. PubMed ID: 7923681
[TBL] [Abstract][Full Text] [Related]
47. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.
Sugioka K; Kodama A; Okada K; Iwata M; Yoshida K; Kusaka S; Matsumoto C; Kaji H; Shimomura Y
Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810
[TBL] [Abstract][Full Text] [Related]
48. Thrombospondin-1 and transforming growth factor-beta l promote breast tumor cell invasion through up-regulation of the plasminogen/plasmin system.
Albo D; Berger DH; Wang TN; Hu X; Rothman V; Tuszynski GP
Surgery; 1997 Aug; 122(2):493-9; discussion 499-500. PubMed ID: 9288157
[TBL] [Abstract][Full Text] [Related]
49. Urokinase receptors in lung cancer and normal lung.
Veale D; Needham G; Harris AL
Anticancer Res; 1990; 10(2A):417-21. PubMed ID: 2161199
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of tumor invasion by genomic down-regulation of matriptase through suppression of activation of receptor-bound pro-urokinase.
Suzuki M; Kobayashi H; Kanayama N; Saga Y; Suzuki M; Lin CY; Dickson RB; Terao T
J Biol Chem; 2004 Apr; 279(15):14899-908. PubMed ID: 14747469
[TBL] [Abstract][Full Text] [Related]
51. Transforming growth factor-beta differently regulates urokinase type plasminogen activator and matrix metalloproteinase-9 expression in mouse macrophages; analysis of intracellular signal transduction.
Mojsilović SS; Santibanez JF
Cell Biol Int; 2015 May; 39(5):619-28. PubMed ID: 25597879
[TBL] [Abstract][Full Text] [Related]
52. Occupancy of the cancer cell urokinase receptor (uPAR): effects of acid elution and exogenous uPA on cell surface urokinase (uPA).
Baker MS; Liang XM; Doe WF
Biochim Biophys Acta; 1992 Sep; 1117(2):143-52. PubMed ID: 1381963
[TBL] [Abstract][Full Text] [Related]
53. Transforming Growth Factor-Beta and Urokinase Type Plasminogen Interplay in Cancer.
Santibanez JF; Krstic J
Curr Protein Pept Sci; 2018; 19(12):1155-1163. PubMed ID: 29086689
[TBL] [Abstract][Full Text] [Related]
54. Transforming growth factor-beta enhances calcitonin-induced cyclic AMP production and the number of calcitonin receptors in long-term cultures of human umbilical cord blood monocytes in the presence of 1,25-dihydroxycholecalciferol.
Mbalaviele G; Orcel P; Bouizar Z; Jullienne A; De Vernejoul MC
J Cell Physiol; 1992 Sep; 152(3):486-93. PubMed ID: 1324244
[TBL] [Abstract][Full Text] [Related]
55. Protein kinase C mediates up-regulation of urokinase and its receptor in the migrating keratinocytes of wounded cultures, but urokinase is not required for movement across a substratum in vitro.
Ando Y; Jensen PJ
J Cell Physiol; 1996 Jun; 167(3):500-11. PubMed ID: 8655604
[TBL] [Abstract][Full Text] [Related]
56. Functional analysis of the cellular receptor for urokinase in plasminogen activation. Receptor binding has no influence on the zymogenic nature of pro-urokinase.
Ellis V
J Biol Chem; 1996 Jun; 271(25):14779-84. PubMed ID: 8662951
[TBL] [Abstract][Full Text] [Related]
57. Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation.
Falcone DJ; McCaffrey TA; Haimovitz-Friedman A; Vergilio JA; Nicholson AC
J Biol Chem; 1993 Jun; 268(16):11951-8. PubMed ID: 8505319
[TBL] [Abstract][Full Text] [Related]
58. Influence of urokinase on cell proliferation and invasion.
Binder BR
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):717-20. PubMed ID: 1966799
[TBL] [Abstract][Full Text] [Related]
59. Alveolar macrophage urokinase receptors localize enzyme activity to the cell surface.
Chapman HA; Bertozzi P; Sailor LZ; Nusrat AR
Am J Physiol; 1990 Dec; 259(6 Pt 1):L432-8. PubMed ID: 2175557
[TBL] [Abstract][Full Text] [Related]
60. Specific inhibition of the activity of the urokinase receptor-mediated cell-surface plasminogen activation system by suramin.
Ellis V; Danø K
Biochem J; 1993 Dec; 296 ( Pt 2)(Pt 2):505-10. PubMed ID: 8257443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
